調査レポート | • レポートコード：GIR-2104Z10968 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、植物性抗がん剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。植物性抗がん剤の種類別市場規模（パクリタキセル、ビノレルビン、イリノテカン、ヒドロキシカンプトテシン、ドセタキセル、その他）、用途別市場規模（卵巣がん、子宮頸がん、乳がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・植物性抗がん剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Phyton、ScinoPharm、Novasep、Samyang、Polymed、TAPI (Teva)、Fresenius-kabi、Huiang biopharma、Southpharma、Yunnan Hande、Hainan Yew Pharm、Jiangsu Yew Biotechnology、West-Ward Pharmaceuticals、Pfizer、Actiza Pharmaceutical、Getwell、Taj Pharma、Cipla、Salius ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：パクリタキセル、ビノレルビン、イリノテカン、ヒドロキシカンプトテシン、ドセタキセル、その他 ・用途別分析2016年-2026年：卵巣がん、子宮頸がん、乳がん、その他 ・植物性抗がん剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・植物性抗がん剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・植物性抗がん剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・植物性抗がん剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・植物性抗がん剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Plant Sources Anti Cancer Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Plant Sources Anti Cancer Agents size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Plant Sources Anti Cancer Agents market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Plant Sources Anti Cancer Agents market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Paclitaxel
Vinorelbine
Irinotecan
Hydroxycamptothecin
Docetaxel
Other
Market segment by Application can be divided into
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
The key market players for global Plant Sources Anti Cancer Agents market are listed below:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
West-Ward Pharmaceuticals
Pfizer
Actiza Pharmaceutical
Getwell
Taj Pharma
Cipla
Salius
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Plant Sources Anti Cancer Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plant Sources Anti Cancer Agents Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Paclitaxel
1.2.3 Vinorelbine
1.2.4 Irinotecan
1.2.5 Hydroxycamptothecin
1.2.6 Docetaxel
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Plant Sources Anti Cancer Agents Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Global Plant Sources Anti Cancer Agents Market Size & Forecast
1.4.1 Global Plant Sources Anti Cancer Agents Sales in Value (2016-2026))
1.4.2 Global Plant Sources Anti Cancer Agents Sales in Volume (2016-2026)
1.4.3 Global Plant Sources Anti Cancer Agents Price by Type (2016-2026) & (USD/Kg)
1.5 Global Plant Sources Anti Cancer Agents Production Capacity Analysis
1.5.1 Global Plant Sources Anti Cancer Agents Total Production Capacity (2016-2026)
1.5.2 Global Plant Sources Anti Cancer Agents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Plant Sources Anti Cancer Agents Market Drivers
1.6.2 Plant Sources Anti Cancer Agents Market Restraints
1.6.3 Plant Sources Anti Cancer Agents Trends Analysis
2 Manufacturers Profiles
2.1 Phyton
2.1.1 Phyton Details
2.1.2 Phyton Major Business
2.1.3 Phyton Plant Sources Anti Cancer Agents Product and Services
2.1.4 Phyton Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 ScinoPharm
2.2.1 ScinoPharm Details
2.2.2 ScinoPharm Major Business
2.2.3 ScinoPharm Plant Sources Anti Cancer Agents Product and Services
2.2.4 ScinoPharm Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novasep
2.3.1 Novasep Details
2.3.2 Novasep Major Business
2.3.3 Novasep Plant Sources Anti Cancer Agents Product and Services
2.3.4 Novasep Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Samyang
2.4.1 Samyang Details
2.4.2 Samyang Major Business
2.4.3 Samyang Plant Sources Anti Cancer Agents Product and Services
2.4.4 Samyang Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Polymed
2.5.1 Polymed Details
2.5.2 Polymed Major Business
2.5.3 Polymed Plant Sources Anti Cancer Agents Product and Services
2.5.4 Polymed Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 TAPI (Teva)
2.6.1 TAPI (Teva) Details
2.6.2 TAPI (Teva) Major Business
2.6.3 TAPI (Teva) Plant Sources Anti Cancer Agents Product and Services
2.6.4 TAPI (Teva) Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Fresenius-kabi
2.7.1 Fresenius-kabi Details
2.7.2 Fresenius-kabi Major Business
2.7.3 Fresenius-kabi Plant Sources Anti Cancer Agents Product and Services
2.7.4 Fresenius-kabi Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Huiang biopharma
2.8.1 Huiang biopharma Details
2.8.2 Huiang biopharma Major Business
2.8.3 Huiang biopharma Plant Sources Anti Cancer Agents Product and Services
2.8.4 Huiang biopharma Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Southpharma
2.9.1 Southpharma Details
2.9.2 Southpharma Major Business
2.9.3 Southpharma Plant Sources Anti Cancer Agents Product and Services
2.9.4 Southpharma Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Yunnan Hande
2.10.1 Yunnan Hande Details
2.10.2 Yunnan Hande Major Business
2.10.3 Yunnan Hande Plant Sources Anti Cancer Agents Product and Services
2.10.4 Yunnan Hande Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Hainan Yew Pharm
2.11.1 Hainan Yew Pharm Details
2.11.2 Hainan Yew Pharm Major Business
2.11.3 Hainan Yew Pharm Plant Sources Anti Cancer Agents Product and Services
2.11.4 Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Jiangsu Yew Biotechnology
2.12.1 Jiangsu Yew Biotechnology Details
2.12.2 Jiangsu Yew Biotechnology Major Business
2.12.3 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product and Services
2.12.4 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 West-Ward Pharmaceuticals
2.13.1 West-Ward Pharmaceuticals Details
2.13.2 West-Ward Pharmaceuticals Major Business
2.13.3 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product and Services
2.13.4 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Pfizer
2.14.1 Pfizer Details
2.14.2 Pfizer Major Business
2.14.3 Pfizer Plant Sources Anti Cancer Agents Product and Services
2.14.4 Pfizer Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Actiza Pharmaceutical
2.15.1 Actiza Pharmaceutical Details
2.15.2 Actiza Pharmaceutical Major Business
2.15.3 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product and Services
2.15.4 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Getwell
2.16.1 Getwell Details
2.16.2 Getwell Major Business
2.16.3 Getwell Plant Sources Anti Cancer Agents Product and Services
2.16.4 Getwell Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Taj Pharma
2.17.1 Taj Pharma Details
2.17.2 Taj Pharma Major Business
2.17.3 Taj Pharma Plant Sources Anti Cancer Agents Product and Services
2.17.4 Taj Pharma Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Cipla
2.18.1 Cipla Details
2.18.2 Cipla Major Business
2.18.3 Cipla Plant Sources Anti Cancer Agents Product and Services
2.18.4 Cipla Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Salius
2.19.1 Salius Details
2.19.2 Salius Major Business
2.19.3 Salius Plant Sources Anti Cancer Agents Product and Services
2.19.4 Salius Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Plant Sources Anti Cancer Agents Sales by Manufacturer
3.1 Global Plant Sources Anti Cancer Agents Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Plant Sources Anti Cancer Agents Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Plant Sources Anti Cancer Agents
3.4 Market Concentration Rate
3.4.1 Top 3 Plant Sources Anti Cancer Agents Manufacturer Market Share
3.4.2 Top 6 Plant Sources Anti Cancer Agents Manufacturer Market Share
3.5 Global Plant Sources Anti Cancer Agents Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Plant Sources Anti Cancer Agents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Plant Sources Anti Cancer Agents Market Size by Region
4.1.1 Global Plant Sources Anti Cancer Agents Sales in Volume by Region (2016-2026)
4.1.2 Global Plant Sources Anti Cancer Agents Revenue by Region (2016-2026)
4.2 North America Plant Sources Anti Cancer Agents Revenue (2016-2026)
4.3 Europe Plant Sources Anti Cancer Agents Revenue (2016-2026)
4.4 Asia-Pacific Plant Sources Anti Cancer Agents Revenue (2016-2026)
4.5 South America Plant Sources Anti Cancer Agents Revenue (2016-2026)
4.6 Middle East and Africa Plant Sources Anti Cancer Agents Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Plant Sources Anti Cancer Agents Sales in Volume by Type (2016-2026)
5.2 Global Plant Sources Anti Cancer Agents Revenue by Type (2016-2026)
5.3 Global Plant Sources Anti Cancer Agents Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Plant Sources Anti Cancer Agents Sales in Volume by Application (2016-2026)
6.2 Global Plant Sources Anti Cancer Agents Revenue by Application (2016-2026)
6.3 Global Plant Sources Anti Cancer Agents Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Plant Sources Anti Cancer Agents Sales by Type (2016-2026)
7.2 North America Plant Sources Anti Cancer Agents Sales by Application (2016-2026)
7.3 North America Plant Sources Anti Cancer Agents Market Size by Country
7.3.1 North America Plant Sources Anti Cancer Agents Sales in Volume by Country (2016-2026)
7.3.2 North America Plant Sources Anti Cancer Agents Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Plant Sources Anti Cancer Agents Sales by Type (2016-2026)
8.2 Europe Plant Sources Anti Cancer Agents Sales by Application (2016-2026)
8.3 Europe Plant Sources Anti Cancer Agents Market Size by Country
8.3.1 Europe Plant Sources Anti Cancer Agents Sales in Volume by Country (2016-2026)
8.3.2 Europe Plant Sources Anti Cancer Agents Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Plant Sources Anti Cancer Agents Sales by Type (2016-2026)
9.2 Asia-Pacific Plant Sources Anti Cancer Agents Sales by Application (2016-2026)
9.3 Asia-Pacific Plant Sources Anti Cancer Agents Market Size by Region
9.3.1 Asia-Pacific Plant Sources Anti Cancer Agents Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Plant Sources Anti Cancer Agents Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Plant Sources Anti Cancer Agents Sales by Type (2016-2026)
10.2 South America Plant Sources Anti Cancer Agents Sales by Application (2016-2026)
10.3 South America Plant Sources Anti Cancer Agents Market Size by Country
10.3.1 South America Plant Sources Anti Cancer Agents Sales in Volume by Country (2016-2026)
10.3.2 South America Plant Sources Anti Cancer Agents Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Plant Sources Anti Cancer Agents Sales by Type (2016-2026)
11.2 Middle East & Africa Plant Sources Anti Cancer Agents Sales by Application (2016-2026)
11.3 Middle East & Africa Plant Sources Anti Cancer Agents Market Size by Country
11.3.1 Middle East & Africa Plant Sources Anti Cancer Agents Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Plant Sources Anti Cancer Agents Typical Distributors
12.3 Plant Sources Anti Cancer Agents Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Plant Sources Anti Cancer Agents Revenue by Type, (USD Million), 2021-2026
Table 2. Global Plant Sources Anti Cancer Agents Revenue by Application, (USD Million), 2021-2026
Table 3. Phyton Basic Information, Manufacturing Base and Competitors
Table 4. Phyton Major Business
Table 5. Phyton Plant Sources Anti Cancer Agents Product and Services
Table 6. Phyton Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 8. ScinoPharm Major Business
Table 9. ScinoPharm Plant Sources Anti Cancer Agents Product and Services
Table 10. ScinoPharm Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novasep Basic Information, Manufacturing Base and Competitors
Table 12. Novasep Major Business
Table 13. Novasep Plant Sources Anti Cancer Agents Product and Services
Table 14. Novasep Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Samyang Basic Information, Manufacturing Base and Competitors
Table 16. Samyang Major Business
Table 17. Samyang Plant Sources Anti Cancer Agents Product and Services
Table 18. Samyang Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Polymed Basic Information, Manufacturing Base and Competitors
Table 20. Polymed Major Business
Table 21. Polymed Plant Sources Anti Cancer Agents Product and Services
Table 22. Polymed Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. TAPI (Teva) Basic Information, Manufacturing Base and Competitors
Table 24. TAPI (Teva) Major Business
Table 25. TAPI (Teva) Plant Sources Anti Cancer Agents Product and Services
Table 26. TAPI (Teva) Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Fresenius-kabi Basic Information, Manufacturing Base and Competitors
Table 28. Fresenius-kabi Major Business
Table 29. Fresenius-kabi Plant Sources Anti Cancer Agents Product and Services
Table 30. Fresenius-kabi Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Huiang biopharma Basic Information, Manufacturing Base and Competitors
Table 32. Huiang biopharma Major Business
Table 33. Huiang biopharma Plant Sources Anti Cancer Agents Product and Services
Table 34. Huiang biopharma Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Southpharma Basic Information, Manufacturing Base and Competitors
Table 36. Southpharma Major Business
Table 37. Southpharma Plant Sources Anti Cancer Agents Product and Services
Table 38. Southpharma Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Yunnan Hande Basic Information, Manufacturing Base and Competitors
Table 40. Yunnan Hande Major Business
Table 41. Yunnan Hande Plant Sources Anti Cancer Agents Product and Services
Table 42. Yunnan Hande Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Hainan Yew Pharm Basic Information, Manufacturing Base and Competitors
Table 44. Hainan Yew Pharm Major Business
Table 45. Hainan Yew Pharm Plant Sources Anti Cancer Agents Product and Services
Table 46. Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Jiangsu Yew Biotechnology Basic Information, Manufacturing Base and Competitors
Table 48. Jiangsu Yew Biotechnology Major Business
Table 49. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product and Services
Table 50. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. West-Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. West-Ward Pharmaceuticals Major Business
Table 53. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product and Services
Table 54. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Major Business
Table 57. Pfizer Plant Sources Anti Cancer Agents Product and Services
Table 58. Pfizer Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Actiza Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Actiza Pharmaceutical Major Business
Table 61. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product and Services
Table 62. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Getwell Basic Information, Manufacturing Base and Competitors
Table 64. Getwell Major Business
Table 65. Getwell Plant Sources Anti Cancer Agents Product and Services
Table 66. Getwell Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Taj Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Taj Pharma Major Business
Table 69. Taj Pharma Plant Sources Anti Cancer Agents Product and Services
Table 70. Taj Pharma Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Cipla Basic Information, Manufacturing Base and Competitors
Table 72. Cipla Major Business
Table 73. Cipla Plant Sources Anti Cancer Agents Product and Services
Table 74. Cipla Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Salius Basic Information, Manufacturing Base and Competitors
Table 76. Salius Major Business
Table 77. Salius Plant Sources Anti Cancer Agents Product and Services
Table 78. Salius Plant Sources Anti Cancer Agents Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Global Plant Sources Anti Cancer Agents Sales by Manufacturer (2019-2021e) & (MT)
Table 80. Global Plant Sources Anti Cancer Agents Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 81. Market Position of Manufacturers in Plant Sources Anti Cancer Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 82. Global Plant Sources Anti Cancer Agents Production Capacity by Company, (MT): 2020 VS 2021
Table 83. Head Office and Plant Sources Anti Cancer Agents Production Site of Key Manufacturer
Table 84. Global Plant Sources Anti Cancer Agents Sales by Region (2016-2021e) & (MT)
Table 85. Global Plant Sources Anti Cancer Agents Sales by Region (2021-2026) & (MT)
Table 86. Global Plant Sources Anti Cancer Agents Revenue by Region (2016-2021e) & (USD Million)
Table 87. Global Plant Sources Anti Cancer Agents Revenue by Region (2021-2026) & (USD Million)
Table 88. Global Plant Sources Anti Cancer Agents Sales by Type (2016-2021e) & (MT)
Table 89. Global Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (MT)
Table 90. Global Plant Sources Anti Cancer Agents Revenue by Type (2016-2021e) & (USD Million)
Table 91. Global Plant Sources Anti Cancer Agents Revenue by Type (2021-2026) & (USD Million)
Table 92. Global Plant Sources Anti Cancer Agents Price by Type (2016-2021e) & (USD/Kg)
Table 93. Global Plant Sources Anti Cancer Agents Price by Type (2021-2026) & (USD/Kg)
Table 94. Global Plant Sources Anti Cancer Agents Sales by Application (2016-2021e) & (MT)
Table 95. Global Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (MT)
Table 96. Global Plant Sources Anti Cancer Agents Revenue by Application (2016-2021e) & (USD Million)
Table 97. Global Plant Sources Anti Cancer Agents Revenue by Application (2021-2026) & (USD Million)
Table 98. Global Plant Sources Anti Cancer Agents Price by Application (2016-2021e) & (USD/Kg)
Table 99. Global Plant Sources Anti Cancer Agents Price by Application (2021-2026) & (USD/Kg)
Table 100. North America Plant Sources Anti Cancer Agents Sales by Country (2016-2021e) & (MT)
Table 101. North America Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (MT)
Table 102. North America Plant Sources Anti Cancer Agents Revenue by Country (2016-2021e) & (USD Million)
Table 103. North America Plant Sources Anti Cancer Agents Revenue by Country (2021-2026) & (USD Million)
Table 104. North America Plant Sources Anti Cancer Agents Sales by Type (2016-2021e) & (MT)
Table 105. North America Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (MT)
Table 106. North America Plant Sources Anti Cancer Agents Sales by Application (2016-2021e) & (MT)
Table 107. North America Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (MT)
Table 108. Europe Plant Sources Anti Cancer Agents Sales by Country (2016-2021e) & (MT)
Table 109. Europe Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (MT)
Table 110. Europe Plant Sources Anti Cancer Agents Revenue by Country (2016-2021e) & (USD Million)
Table 111. Europe Plant Sources Anti Cancer Agents Revenue by Country (2021-2026) & (USD Million)
Table 112. Europe Plant Sources Anti Cancer Agents Sales by Type (2016-2021e) & (MT)
Table 113. Europe Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (MT)
Table 114. Europe Plant Sources Anti Cancer Agents Sales by Application (2016-2021e) & (MT)
Table 115. Europe Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (MT)
Table 116. Asia-Pacific Plant Sources Anti Cancer Agents Sales by Region (2016-2021e) & (MT)
Table 117. Asia-Pacific Plant Sources Anti Cancer Agents Sales by Region (2021-2026) & (MT)
Table 118. Asia-Pacific Plant Sources Anti Cancer Agents Revenue by Region (2016-2021e) & (USD Million)
Table 119. Asia-Pacific Plant Sources Anti Cancer Agents Revenue by Region (2021-2026) & (USD Million)
Table 120. Asia-Pacific Plant Sources Anti Cancer Agents Sales by Type (2016-2021e) & (MT)
Table 121. Asia-Pacific Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (MT)
Table 122. Asia-Pacific Plant Sources Anti Cancer Agents Sales by Application (2016-2021e) & (MT)
Table 123. Asia-Pacific Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (MT)
Table 124. South America Plant Sources Anti Cancer Agents Sales by Country (2016-2021e) & (MT)
Table 125. South America Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (MT)
Table 126. South America Plant Sources Anti Cancer Agents Revenue by Country (2016-2021e) & (USD Million)
Table 127. South America Plant Sources Anti Cancer Agents Revenue by Country (2021-2026) & (USD Million)
Table 128. South America Plant Sources Anti Cancer Agents Sales by Type (2016-2021e) & (MT)
Table 129. South America Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (MT)
Table 130. South America Plant Sources Anti Cancer Agents Sales by Application (2016-2021e) & (MT)
Table 131. South America Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (MT)
Table 132. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Country (2016-2021e) & (MT)
Table 133. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (MT)
Table 134. Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Country (2016-2021e) & (USD Million)
Table 135. Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Country (2021-2026) & (USD Million)
Table 136. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Type (2016-2021e) & (MT)
Table 137. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (MT)
Table 138. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Application (2016-2021e) & (MT)
Table 139. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (MT)
Table 140. Direct Channel Pros & Cons
Table 141. Indirect Channel Pros & Cons
Table 142. Plant Sources Anti Cancer Agents Typical Distributors
Table 143. Plant Sources Anti Cancer Agents Typical Customers
List of Figures
Figure 1. Plant Sources Anti Cancer Agents Picture
Figure 2. Global Plant Sources Anti Cancer Agents Sales Market Share by Type in 2020
Figure 3. Paclitaxel
Figure 4. Vinorelbine
Figure 5. Irinotecan
Figure 6. Hydroxycamptothecin
Figure 7. Docetaxel
Figure 8. Other
Figure 9. Global Plant Sources Anti Cancer Agents Sales Market Share by Application in 2020
Figure 10. Ovarian Cancer
Figure 11. Cervical Cancer
Figure 12. Breast Cancer
Figure 13. Other
Figure 14. Global Plant Sources Anti Cancer Agents Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 15. Global Plant Sources Anti Cancer Agents Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Plant Sources Anti Cancer Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Plant Sources Anti Cancer Agents Sales (2016-2026) & (MT)
Figure 36. Global Plant Sources Anti Cancer Agents Production Capacity (2016-2026) & (MT)
Figure 37. Global Plant Sources Anti Cancer Agents Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Plant Sources Anti Cancer Agents Market Drivers
Figure 39. Plant Sources Anti Cancer Agents Market Restraints
Figure 40. Plant Sources Anti Cancer Agents Market Trends
Figure 41. Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturer in 2020
Figure 42. Global Plant Sources Anti Cancer Agents Revenue Market Share by Manufacturer in 2020
Figure 43. Plant Sources Anti Cancer Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Plant Sources Anti Cancer Agents Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Plant Sources Anti Cancer Agents Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2016-2026)
Figure 47. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2016-2026)
Figure 48. North America Plant Sources Anti Cancer Agents Revenue (2016-2026) & (USD Million)
Figure 49. Europe Plant Sources Anti Cancer Agents Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Plant Sources Anti Cancer Agents Revenue (2016-2026) & (USD Million)
Figure 51. South America Plant Sources Anti Cancer Agents Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Plant Sources Anti Cancer Agents Revenue (2016-2026) & (USD Million)
Figure 53. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2016-2026)
Figure 54. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2016-2026)
Figure 55. Global Plant Sources Anti Cancer Agents Price by Type (2016-2026) & (USD/Kg)
Figure 56. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2016-2026)
Figure 57. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2016-2026)
Figure 58. Global Plant Sources Anti Cancer Agents Price by Application (2016-2026) & (USD/Kg)
Figure 59. North America Plant Sources Anti Cancer Agents Sales Market Share by Country (2016-2026)
Figure 60. North America Plant Sources Anti Cancer Agents Revenue Market Share by Country (2016-2026)
Figure 61. North America Plant Sources Anti Cancer Agents Sales Market Share by Type (2016-2026)
Figure 62. North America Plant Sources Anti Cancer Agents Sales Market Share by Application (2016-2026)
Figure 63. Europe Plant Sources Anti Cancer Agents Sales Market Share by Country (2016-2026)
Figure 64. Europe Plant Sources Anti Cancer Agents Revenue Market Share by Country (2016-2026)
Figure 65. Europe Plant Sources Anti Cancer Agents Sales Market Share by Type (2016-2026)
Figure 66. Europe Plant Sources Anti Cancer Agents Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Plant Sources Anti Cancer Agents Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Plant Sources Anti Cancer Agents Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Plant Sources Anti Cancer Agents Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Plant Sources Anti Cancer Agents Sales Market Share by Application (2016-2026)
Figure 71. South America Plant Sources Anti Cancer Agents Sales Market Share by Country (2016-2026)
Figure 72. South America Plant Sources Anti Cancer Agents Revenue Market Share by Country (2016-2026)
Figure 73. South America Plant Sources Anti Cancer Agents Sales Market Share by Type (2016-2026)
Figure 74. South America Plant Sources Anti Cancer Agents Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Plant Sources Anti Cancer Agents Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Plant Sources Anti Cancer Agents Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Plant Sources Anti Cancer Agents Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Plant Sources Anti Cancer Agents Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の抗腫瘍剤市場 2021：企業別、地域別、種類・用途別 The Anti - Neoplastic Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 世界の卵巣がん市場規模・現状・予測（2021年-2027年） Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. North America dominates the global market for ovarian cancer due to large number of aging …
- 世界のトリプルネガティブ乳がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Triple-Negative Breast Cancer Treatment Market The global Triple-Negative Breast Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の子宮頸がん診断検査市場規模・現状・予測（2021年-2027年） Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Market Analysis and Insights: Global Cervical Cancer Diagnostic Tests Market The global Cervical Cancer Diagnostic Tests market size is…